Dan Zhao

Title: Dan Zhao: Innovator in Cancer Treatment Technologies

Introduction

Dan Zhao is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of cancer treatment through his innovative work on chimeric antigen receptors. With a total of 2 patents, Zhao is recognized for his advancements in targeted therapies.

Latest Patents

Zhao's latest patents focus on chimeric antigen receptors targeting BCMA (B-cell maturation antigen). The first patent provides single-domain antibodies targeting BCMA, along with chimeric antigen receptors that include monovalent CAR and multivalent CAR configurations. These innovations also encompass engineered immune effector cells, such as T cells, that incorporate these chimeric antigen receptors. Additionally, pharmaceutical compositions, kits, and methods for treating cancer are included in this patent. The second patent reiterates these advancements, emphasizing the development of single-domain antibodies and engineered immune effector cells for effective cancer treatment.

Career Highlights

Dan Zhao is currently associated with Legend Biotech USA Inc., where he continues to push the boundaries of cancer research and treatment. His work is pivotal in the development of novel therapies that aim to improve patient outcomes.

Collaborations

Zhao collaborates with notable colleagues, including Xiaohu Fan and Qiuchuan Zhuang, who contribute to his research efforts and innovations in the field.

Conclusion

Dan Zhao's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the biotechnology sector. His work continues to pave the way for advancements in targeted cancer therapies.